Novartis enters licensing agreement with UNP for peptide therapeutics
Under the agreement, UNP will receive up to $100m in upfront and pre-IND milestone payments.
Drug Development
MSD and Mayo Clinic team up to advance AI in drug development
Evogene and QUT partner on AI-based cancer therapies
J&J’s Rybrevant Faspro gains FDA approval for new dosing in NSCLC
RNA-targeting small molecules: a new frontier of drug discovery
Teijin and Aska Pharmaceutical to co-develop gynaecological drugs
ExCellThera secures German NUB Status 1 listing for Zemcelpro
FDA issues complete response letter to Disc Medicine’s bitopertin NDA
